Hypertension and diabetes control: faith-based centres offer a promise for expanding screening services and linkage to care in Ghana.


Journal

BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 08 07 2024
accepted: 08 10 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Hypertension and type 2 diabetes mellitus (T2DM) are important contributors to noncommunicable disease related morbidity and mortality. Health systems could benefit from exploring the use of Faith-Based Centres (FBC) to screen and link suspected cases for further care in order to help achieve Sustainable Development Goal (SDG) 3. The study investigated the role of faith-based screening for T2DM and hypertension and the linkage of cases to the healthcare system and examined the care cascade in the Kassena Nankana Districts of Northern Ghana. We screened individuals from 6 FBCs for elevated blood pressure and hyperglycaemia. Suspected hypertension and T2DM cases were referred to health facilities for confirmation and subsequently followed them up for 3 months. We assessed the prevalence of behavioural and metabolic risk factors, including hypertension and T2DM, and the retention of referred cases in the healthcare system over follow up period. We further assessed levels of awareness, treatment and adequate control of hypertension and T2DM. A total of 631 participants were screened, (mean age 49 ± 16years, 73% female) from 6 Faith based Centres. More males than females reported smoking tobacco (14.5% vs. 0.7%) and been physically active (64.5% vs. 52.7%) while more females were obese (29.6 kg/m Faith-based centres have the potential to enhance the screening, linkage to the healthcare system, and management of hypertension and T2DM. This improvement over the routine system could lead to earlier diagnoses, a reduction in complications, and decreased premature mortality from cardiovascular diseases. Consequently, these efforts would contribute significantly to achieving SDG 3.

Sections du résumé

BACKGROUND BACKGROUND
Hypertension and type 2 diabetes mellitus (T2DM) are important contributors to noncommunicable disease related morbidity and mortality. Health systems could benefit from exploring the use of Faith-Based Centres (FBC) to screen and link suspected cases for further care in order to help achieve Sustainable Development Goal (SDG) 3. The study investigated the role of faith-based screening for T2DM and hypertension and the linkage of cases to the healthcare system and examined the care cascade in the Kassena Nankana Districts of Northern Ghana.
METHODS METHODS
We screened individuals from 6 FBCs for elevated blood pressure and hyperglycaemia. Suspected hypertension and T2DM cases were referred to health facilities for confirmation and subsequently followed them up for 3 months. We assessed the prevalence of behavioural and metabolic risk factors, including hypertension and T2DM, and the retention of referred cases in the healthcare system over follow up period. We further assessed levels of awareness, treatment and adequate control of hypertension and T2DM.
RESULTS RESULTS
A total of 631 participants were screened, (mean age 49 ± 16years, 73% female) from 6 Faith based Centres. More males than females reported smoking tobacco (14.5% vs. 0.7%) and been physically active (64.5% vs. 52.7%) while more females were obese (29.6 kg/m
CONCLUSION CONCLUSIONS
Faith-based centres have the potential to enhance the screening, linkage to the healthcare system, and management of hypertension and T2DM. This improvement over the routine system could lead to earlier diagnoses, a reduction in complications, and decreased premature mortality from cardiovascular diseases. Consequently, these efforts would contribute significantly to achieving SDG 3.

Identifiants

pubmed: 39448912
doi: 10.1186/s12875-024-02620-0
pii: 10.1186/s12875-024-02620-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

382

Informations de copyright

© 2024. The Author(s).

Références

Atibila F, ten Hoor G, Donkor ET, Wahab AI, Kok G. Prevalence of hypertension in Ghanaian society: a systematic review, meta-analysis, and GRADE assessment. Systemic Reviews. 2021;10:220.
doi: 10.1186/s13643-021-01770-x
Tannor EK, Nyarko OO, Adu-Boakye Y, Konadu SO, Opoku G, Ankobea-Kokroe F, et al. Prevalence of hypertension in Ghana: analysis of an awareness and screening campaign in 2019. Clin Med Insights: Cardiol. 2021;16:1–7. https://doi.org/10.1177/179546822110092 .
doi: 10.1177/179546822110092
Bosu WK, Bosu DK. Prevalence, awareness and control of hypertension in Ghana: a systematic review and meta-analysis. PLoS ONE. 2021;16(3):e0248137. https://doi.org/10.1371/journal .
doi: 10.1371/journal pubmed: 33667277 pmcid: 7935309
Kunustor, Powles J. Descriptive epidemiology of blood pressure in a rural adult population in Northern Ghana. Rural Remote Health. 2009;9:1095.
Gómez-Olivé FX, Ali SA, Made F, Kyobutungi C, Nonterah E, Micklesfield L, et al. Regional and Sex differences in the prevalence and awareness of hypertension: an H3Africa AWI-Gen Study Across 6 sites in Sub-saharan Africa. Glob Heart. 2017;12(2):81–90. https://doi.org/10.1016/j.gheart.2017.01.007 .
doi: 10.1016/j.gheart.2017.01.007 pubmed: 28302553
Wade AN, Maposa I, Agongo G, Asiki G, Boua P, Choma SSR, et al. Diabetes care cascade and associated factors in 10700 middle-aged adults in four sub-saharan African: a cross-sectional study. BMJ Open. 2023;13(4):e069193. https://doi.org/10.1136/bmjopen-2022-069193 .
doi: 10.1136/bmjopen-2022-069193 pubmed: 37105688 pmcid: 10151877
Ghana Health Service. Implementation guidelines for networks of practice 2024. Accra, Ghana.
Brewer LC, Bowie J, Slusser JP, Scott CG, Cooper LA, Hayes SN. et at. Religiosity/Spirituality and Cardiovascular Health: The American Heart Association Life’s Simple 7 in African Americans of the Jackson Heart Study. J Am Heart Assoc. 2022; 11:e024974. https://doi.org/10.1161/JAHA.121.024974
Ghana Statistical Service. Population and Housing Census 2021 (PHC 2021). https://census2021. statsghana.gov.gh
Willis A, Chatio S, Darko N, Nonterah EA, Zakariah-Akoto S, Alale J, et al. Cardiovascular disease prevention: Community Asset mapping within religious networks in rural sub-saharan African neighbourhood. PLOS Glob Public Health. 2023;3(10):e0002201. https://doi.org/10.1371/journal.pgph.0002201 .
doi: 10.1371/journal.pgph.0002201 pubmed: 37862285 pmcid: 10588837
Oduro AR, Wak G, Azongo D, Debpuur CY, Wontuo P, et al. Profile of the Navrongo health and demographic Surveillance System. Int J Epidemiol. 2012;41(4):968–76. https://doi.org/10.1093/ije/dys111 .
doi: 10.1093/ije/dys111 pubmed: 22933645
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based Guideline for the management of high blood pressure in adults: report from the Panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507.
doi: 10.1001/jama.2013.284427 pubmed: 24352797
American Diabetes Association Professional Practice Committee. Classification and diagnosis of diabetes: standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(Supplement1):S83–96.
doi: 10.2337/dc22-S006
Nonterah EA, Debpuur C, Agongo G, Amenga-Etego L, Crowther NJ, et al. Socio-demographic and behavioural determinants of body mass index among an adult population in rural Northern Ghana: the AWI-Gen study. Glob Health Action. 2018;11(sup2):1467588. https://doi.org/10.1080/16549716.2018.1467588 .
doi: 10.1080/16549716.2018.1467588 pubmed: 29992851 pmcid: 6041816
Ofori-Asenso R, Agyemang AA, Laar A, Boateng D. Overweight and obesity in Ghana - a systematic review and meta-analysis. BMC Pub health. 2016; 16:1239. https://doi.10.1186/s12889-016-3901-4.
Agyapong NAF, Annan RA, Apprey C, Aduku LNE. Body weight, obesity perception, and actions to achieve desired weight among rural and urban Ghanaian adults. Journal of obesity. 2020; 2020:1. https://doi.org/10.1155/2020/7103251
NCD Risk Factor Collaboration (NCD-Risk). Rising rural body mass index is the main driver of global obesity epidemic in adults. Nature. 2019;569(7755):260–4. https://doi.org/10.1038/s41586-019-1171-x .
doi: 10.1038/s41586-019-1171-x
GBD Diabetes collaborators. Global, regional, national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of Disease Study 2021. Lancet. 2023;402:203–34. https://doi.org/10.1016/S0140-6736(23)01301-6 .
doi: 10.1016/S0140-6736(23)01301-6
Ye J, Wu Y, Yang S, Zhu D, Chen F, Chen J, Ji X, Hou K. (2023) The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019. Front. Endocrinol 2023. 14:1192629. https://doi.org/10.3389/fendo.2023.1192629
Pogosova N. May Month Measurement: beyond boosting hypertension awareness. Lancet. 2022;10:e1141. https://doi.org/10.1016/s2214-109x(22)00270-4:10 .
doi: 10.1016/s2214-109x(22)00270-4:10
Babagoli MA, Adu-Amankwah D, Nonterah EA, Aborigo RA, Kuwolamo I, Jones KR, et al. Sociodemographic and behavioral factors associated with hypertension and depression in 4 rural communities in Northern Ghana: a cross-sectional study. J Prim Care Community Health. 2024. https://doi.org/10.1177/21501319241242965 .
doi: 10.1177/21501319241242965 pubmed: 38577795 pmcid: 10998485
Elhag M, Awaisu A, Koenia HG, Ibrahim MIM. The association between religiosity, spirituality and medication adherence among patients with cardiovascular diseases: a systematic review of the literature. J Relig Health. 2022;61(5):3988–4027.
doi: 10.1007/s10943-022-01525-5 pubmed: 35274225 pmcid: 9509306
Kasahun AE, Sendekie AK, Mekonnen GA, Sema FD, Kemal LK, Abebe RB. Impact of personal, cultural and religious beliefs on medication adherence among patients with chronic disease at a university hospital in Northwest Ethiopia. Patient Prefer Adherence. 2022;16:1787–803. https://doi.org/10.2147/PPA.S370178 .
doi: 10.2147/PPA.S370178 pubmed: 35923657 pmcid: 9342701

Auteurs

Engelbert A Nonterah (EA)

Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana. drenanonterah@gmail.com.
Department of Epidemiology, School of Public Health, CK Tedam University of Technology and Applied Sciences, Navrongo, Ghana. drenanonterah@gmail.com.
Julius Centre for Health Science and Primary Care, Julius Global Health, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands. drenanonterah@gmail.com.

Samuel T Chatio (ST)

Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.
Department of Epidemiology, School of Public Health, CK Tedam University of Technology and Applied Sciences, Navrongo, Ghana.

Andy Willis (A)

School of Public Health and HRB Clinical Research Facility, University College, Cork, Ireland.

Joseph A Alale (JA)

Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.

Sawudatu Zakariah-Akoto (S)

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.

Natalie Darko (N)

Leicester NIHR Biomedical Research Centre, College of Life Sciences, University of Leicester, Leicester, UK.

Ffion Curtis (F)

Leicester Diabetes Centre, University of Leicester, Leicester, UK.

Setor K Kunutsor (SK)

Section of Cardiology, Department of Internal Medicine, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Saint Boniface Hospital, Winnipeg, MB, R2H 2A6, Canada.

Ceri Jones (C)

Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.

Samuel Seidu (S)

Leicester NIHR Biomedical Research Centre, College of Life Sciences, University of Leicester, Leicester, UK.
Leicester Diabetes Centre, University of Leicester, Leicester, UK.

Patrick O Ansah (PO)

Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.
Department of Epidemiology, School of Public Health, CK Tedam University of Technology and Applied Sciences, Navrongo, Ghana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH